Schedule 13D ownership disclosure

PHARMAGEN INC

Security class unavailable · CUSIP: 71715W106

Event date: 2014-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001477932-14-003004
Form type
SC 13D
Filer
Pharmagen, Inc.
CIK
CIK 1470915
Filed
Jun 04, 2014
Reporting period
Feb 14, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub